341 related articles for article (PubMed ID: 32734614)
21. The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts.
Ji L; Liu Y; Zhang Y; Chang W; Gong J; Wei S; Li X; Qin L
Can J Physiol Pharmacol; 2016 Sep; 94(9):996-1006. PubMed ID: 27376621
[TBL] [Abstract][Full Text] [Related]
22. High Fat Diet Upregulates Fatty Acid Oxidation and Ketogenesis via Intervention of PPAR-γ.
Sikder K; Shukla SK; Patel N; Singh H; Rafiq K
Cell Physiol Biochem; 2018; 48(3):1317-1331. PubMed ID: 30048968
[TBL] [Abstract][Full Text] [Related]
23. New mechanism of lipotoxicity in diabetic cardiomyopathy: Deficiency of Endogenous H
Guo R; Wu Z; Jiang J; Liu C; Wu B; Li X; Li T; Mo H; He S; Li S; Yan H; Huang R; You Q; Wu K
Mech Ageing Dev; 2017 Mar; 162():46-52. PubMed ID: 27871808
[TBL] [Abstract][Full Text] [Related]
24. Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.
Li L; Chen X; Su C; Wang Q; Li R; Jiao W; Luo H; Tian Y; Tang J; Li X; Liu B; Wang W; Zhang D; Guo S
Biomed Pharmacother; 2020 Dec; 132():110817. PubMed ID: 33068937
[TBL] [Abstract][Full Text] [Related]
25. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
[TBL] [Abstract][Full Text] [Related]
26. Galectin-3 mediates high-glucose-induced cardiomyocyte injury by the NADPH oxidase/reactive oxygen species pathway.
Sun J; Zhang L; Fang J; Yang S; Chen L
Can J Physiol Pharmacol; 2020 Nov; 98(11):826-833. PubMed ID: 32311288
[TBL] [Abstract][Full Text] [Related]
27. GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress.
Feng W; Lei T; Wang Y; Feng R; Yuan J; Shen X; Wu Y; Gao J; Ding W; Lu Z
Free Radic Biol Med; 2019 Jan; 130():128-139. PubMed ID: 30389499
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
Yu M; Sun Y; Shan X; Yang F; Chu G; Chen Q; Han L; Guo Z; Wang G
Cell Mol Biol Lett; 2022 Oct; 27(1):85. PubMed ID: 36209049
[TBL] [Abstract][Full Text] [Related]
29. Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats.
Trang NN; Chung CC; Lee TW; Cheng WL; Kao YH; Huang SY; Lee TI; Chen YJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503985
[TBL] [Abstract][Full Text] [Related]
30. Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress.
Cai W; Chong K; Huang Y; Huang C; Yin L
Redox Biol; 2024 Feb; 69():103010. PubMed ID: 38160540
[TBL] [Abstract][Full Text] [Related]
31. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
[TBL] [Abstract][Full Text] [Related]
32. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.
Kyriazis ID; Hoffman M; Gaignebet L; Lucchese AM; Markopoulou E; Palioura D; Wang C; Bannister TD; Christofidou-Solomidou M; Oka SI; Sadoshima J; Koch WJ; Goldberg IJ; Yang VW; Bialkowska AB; Kararigas G; Drosatos K
Circ Res; 2021 Feb; 128(3):335-357. PubMed ID: 33539225
[TBL] [Abstract][Full Text] [Related]
33. Effects of PPARα/PGC-1α on the energy metabolism remodeling and apoptosis in the doxorubicin induced mice cardiomyocytes in vitro.
Yang Y; Zhang H; Li X; Yang T; Jiang Q
Int J Clin Exp Pathol; 2015; 8(10):12216-24. PubMed ID: 26722406
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
35. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
36. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis.
Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D
J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607
[TBL] [Abstract][Full Text] [Related]
37. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
[TBL] [Abstract][Full Text] [Related]
38. [Exendin-4 alleviates diabetic cardiomyopathy in mice by regulating Sirt1/PGC1α].
Cai YY; Zou SZ; Fan CX; Wu CY; Fang S; Li P; Xue YM; Guan MP
Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):520-526. PubMed ID: 29891446
[TBL] [Abstract][Full Text] [Related]
39. Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes.
Hou N; Luo MS; Liu SM; Zhang HN; Xiao Q; Sun P; Zhang GS; Luo JD; Chen MS
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1087-95. PubMed ID: 20738325
[TBL] [Abstract][Full Text] [Related]
40. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
